Re: Chew et al.: Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? (Ophthalmology 2015;122:212-5)

I have read with great interest this brief report claiming the universal recommendation for Age-Related Eye Disease Study (AREDS) supplements.1 Because this recommendation is of substantial importance to public health, affects tens of millions of patients, and is mandated by a Physician Quality Reporting System (PQRS) measure, the issue deserves further scrutiny.